| Financial Year |
September 30 2017 |
| Monetary Funds |
58,618,636.41 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
279,834,840.64 |
| Advances to Suppliers |
37,818,721.93 |
| Other Receivables |
6,288,362.83 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
3,720,000.00 |
| Inventories |
30,853,227.11 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
594,531.64 |
| Other Current Assets |
2,330,188.69 |
| Total Current Assets |
420,058,509.25 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
420,283,910.83 |
| Under-construction Projects |
27,600,720.21 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
122,412,182.63 |
| R&D expenses |
-- |
| Goodwill |
999,801.06 |
| Long-Term Deferred and Prepaid Expenses |
-- |
| Deferred Income Tax Assets |
18,167,724.27 |
| Other Non-Current Assets |
95,873,750.00 |
| Sub-Total of Non-Current Assets |
685,338,089.00 |
| Total Assets |
1,105,396,598.25 |
| Short-Term Loans |
68,000,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
51,001,589.12 |
| Accounts Received In Advance |
18,954,710.09 |
| Employee Compensation Payable |
7,606,905.12 |
| Taxes Payable |
16,150,730.45 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
2,929,877.85 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
474,646.41 |
| Other Current Liabilities |
-- |
| Sub-Total of Current Liabilities |
165,118,459.04 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
140,787.73 |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
275,311.29 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
143,038,068.70 |
| Total Liabilities |
308,156,527.74 |
| Paid-In Capital(Or Share Stock) |
360,302,400.00 |
| Capital Surplus |
18,266,110.37 |
| Surplus Reserve |
51,910,678.18 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
365,833,979.82 |
| Minority Stockholder's Interest |
926,902.14 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
796,313,168.37 |
| Owner's Equity（Stockholder's Equity） |
797,240,070.51 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,105,396,598.25 |
